title: Colonoscopy: the current king of the hill in the USA.
abstract: Colonoscopy is the dominant colorectal cancer screening strategy in the USA. There are no randomized controlled trials completed of screening colonoscopy, but multiple lines of evidence establish that colonoscopy reduces colorectal cancer incidence in both the proximal and distal colon. Colonoscopy is highly operator dependent, but systematic efforts to measure and improve quality are impacting performance. Colonoscopy holds a substantial advantage over other strategies for detection of serrated lesions, and a recent case-control study suggests that once-only colonoscopy or colonoscopy at 20-year intervals, by a high-level detector, could ensure lifetime protection from colorectal cancer for many patients.
authors.affiliation: Division of Gastroenterology/Hepatology, Department of Medicine, Indiana University School of Medicine, 550 N. University Boulevard, Indiana University Hospital #4100, Indianapolis, IN, 46202, USA, drex@iupui.edu.
authors.forename: Douglas K
authors.initials: DK
authors.lastname: Rex
mesh_terms: D002983:Clinical Competence; D003111:Colonic Polyps / Q000175:diagnosis*; D003113:Colonoscopy / Q000592:standards / Q000639:trends*; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000639:trends; D011785:Quality Assurance, Health Care; D014481:United States